— Published date: 4/18/2026
Value Proposition: Combination cancer therapy that utilizes long non-coding RNA and CDK4/6 inhibitors to treat breast cancer.
Technology Description
Researchers at Washington University in St. Louis have developed a cancer combination therapy using CDK4/6 inhibitors an…
— Published date: 4/18/2026
Value Proposition: Method that uses ultrasound to detect functional nephron number in the kidneys.
Technology Description
Current clinical markers of kidney health (serum creatinine and estimated glomerular filtration rate (eGFR)) are insensitive to the early progressi…
— Published date: 1/14/2026
Value Proposition: Novel target for therapeutic treatment of obesity and related metabolic diseases.
Technology Description
Researchers at Washington University in St. Louis have developed a therapeutic targeting MXRA8 to treat obesity and associated metabolic disea…
— Published date: 1/13/2026
Value Proposition: Predictive biomarkers that can identify patients that would respond well to HER2 targeted breast cancer treatment that are not currently being treated this way.
Technology Description
Researchers at Washington University in St. Louis have establis…
— Published Date: 1/4/2025
Value Proposition: New composition of matter that combines tetracycline class compounds with destructase inhibitors to overcome resistance to tetracycline antibiotics.
Technology Description
Researchers at Washington University in St. Louis have developed an enzymatic…
| Name | # Summaries | Author |
|---|---|---|
| 15 | ||
| 13 | ||
| 15 | ||
| 26 | ||
| 14 | ||
| 14 |
Creating...
